Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Menezes

Showing results (291-300 of 301) with videos related to

Pageof 31
Sort By:
Heart (British Cardiac Society)|May 25, 2022
United Kingdom standards for non-invasive cardiac imaging: recommendations from the Imaging Council of the British Cardiovascular SocietyThomas A Treibel, Andrew Kelion, Thomas E Ingram, et al.
ESMO Open|May 30, 2025
Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LAD P Carbone, T-E Ciuleanu, M Cobo, et al.
Journal of the American College of Cardiology|November 12, 2020
Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac AmyloidosisChristian Nitsche, Paul R Scully, Kush P Patel, et al.
Science Advances|November 1, 2024
Pathogenic mitochondrial DNA mutations inhibit melanoma metastasisSpencer D Shelton, Sara House, Luiza Martins Nascentes Melo, et al.
ESMO Open|December 5, 2021
Corrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273]M Reck, T-E Ciuleanu, M Cobo, et al.
ESMO Open|October 4, 2021
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year updateM Reck, T-E Ciuleanu, M Cobo, et al.
The Lancet. Digital Health|March 22, 2024
Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross-tracer development and validation studyClemens P Spielvogel, David Haberl, Katharina Mascherbauer, et al.
Science (New York, N.Y.)|January 6, 2018
Transferrin receptor 1 is a reticulocyte-specific receptor for <i>Plasmodium vivax</i>Jakub Gruszczyk, Usheer Kanjee, Li-Jin Chan, et al.
Science (New York, N.Y.)|June 13, 2024
Metabolic inflexibility promotes mitochondrial health during liver regenerationXun Wang, Cameron J Menezes, Yuemeng Jia, et al.
The Journal of Infectious Diseases|March 24, 2022
Age-Specific Prevalence of Anal and Cervical Human Papillomavirus Infection and High-Grade Lesions in 11 177 Women by Human Immunodeficiency Virus Status: A Collaborative Pooled Analysis of 26 StudiesFeixue Wei, Ningshao Xia, Rebeca Ocampo, et al.
Pageof 31

Showing results (291-300 of 301) with videos related to

Sort By:
Pageof 31
Heart (British Cardiac Society)|May 25, 2022
United Kingdom standards for non-invasive cardiac imaging: recommendations from the Imaging Council of the British Cardiovascular SocietyThomas A Treibel, Andrew Kelion, Thomas E Ingram, et al.
ESMO Open|May 30, 2025
Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LAD P Carbone, T-E Ciuleanu, M Cobo, et al.
Journal of the American College of Cardiology|November 12, 2020
Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac AmyloidosisChristian Nitsche, Paul R Scully, Kush P Patel, et al.
Science Advances|November 1, 2024
Pathogenic mitochondrial DNA mutations inhibit melanoma metastasisSpencer D Shelton, Sara House, Luiza Martins Nascentes Melo, et al.
ESMO Open|December 5, 2021
Corrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273]M Reck, T-E Ciuleanu, M Cobo, et al.
ESMO Open|October 4, 2021
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year updateM Reck, T-E Ciuleanu, M Cobo, et al.
The Lancet. Digital Health|March 22, 2024
Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross-tracer development and validation studyClemens P Spielvogel, David Haberl, Katharina Mascherbauer, et al.
Science (New York, N.Y.)|January 6, 2018
Transferrin receptor 1 is a reticulocyte-specific receptor for <i>Plasmodium vivax</i>Jakub Gruszczyk, Usheer Kanjee, Li-Jin Chan, et al.
Science (New York, N.Y.)|June 13, 2024
Metabolic inflexibility promotes mitochondrial health during liver regenerationXun Wang, Cameron J Menezes, Yuemeng Jia, et al.
The Journal of Infectious Diseases|March 24, 2022
Age-Specific Prevalence of Anal and Cervical Human Papillomavirus Infection and High-Grade Lesions in 11 177 Women by Human Immunodeficiency Virus Status: A Collaborative Pooled Analysis of 26 StudiesFeixue Wei, Ningshao Xia, Rebeca Ocampo, et al.
Pageof 31